Autologous Stem Cell Systemic Sclerosis Immune Suppression Trial

NCT01445821 · clinicaltrials.gov ↗

PHASE3

Phase

TERMINATED

Status

44

Enrollment

OTHER

Sponsor class

Stopped Developed a better regimen: DIAD. Cast. 2018 NCT03593902

Conditions

Scleroderma, Systemic

Interventions

BIOLOGICAL: Peripheral Blood Stem Cells
DRUG: Cyclophosphamide
DRUG: Mesna
DRUG: rATG
DRUG: Methylprednisolone
DRUG: Filgrastim
DRUG: Fludarabine

Sponsor

Northwestern University